soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Semaglutide and Cardiovascular Outcomes in

Understanding these important points can help individuals navigate their weight loss journey with greater confidence

Whats important from a metabolic standpoint is that improvements are closely tied to meaningful weight loss and improved insulin resistance, reinforcing that we are increasingly treating type 2 diabetes as part of a broader chronic metabolic disease driven by excess adiposity [body fat], says Abdelmasih

Understanding that night sweats could be linked to semaglutide use is important for both patients and healthcare providers

Frequently Asked Questions How long do weight loss plateaus typically last on GLP-1 medications like Wegovy